• Próximos Congresos: 13
• > Congresos

Capel M, Ciudin A, Mareque M, Rodríguez-Rincón RM, Oyagüez I

Cost-effectiveness analysis of exenatide versus GLP-1 receptor agonists in patients with type 2 Diabetes Mellitus

21th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018

de Andrés-Nogales F, Oyagüez I, Morell A, Casado MÁ

Cost analysis of botulinum toxin A (Botox® and Xeomin®) in real-world clinical practice

21th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018

Casado MA, de Andrés-Nogales F, Ignacio E, Ortiz P, Peralta G, Poveda JL, Ruiz Moreno JM, Sabater E, Trillo JL, Zarranz-Ventura J, Grupo MULTIDEX-EMD

A Multi-Stakeholder Multicriteria decision analysis in Diabetic Macular Edema. MULTIDEX-EMD Study

21th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018

de Andrés-Nogales F, Oyagüez I, Suárez C, López-Sendón JL, González-Juanatey JR, Suarez J, Polanco C

Cost-effectiveness analysis of apixaban versus edoxaban for stroke prevention in non-valvular atrial fibrillation Spanish patients 

21th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018

Castañeda S, Vicente-Rabaneda EF, Calvo-Alén J, Gómez A, Miranda MD, Martínez Pardo S, Merino L, Llamas-Velasco M, Casado A, Amaro A, Sabater E, Yébenes M, COEPSO Study Group

Patient’s preferences for treatment of psoriatic arthritis based on a discrete choice experiment. Results of the COEPSO study

21th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018

Llamas-Velasco M, Sánchez-Pérez J, Pardo J, Cabeza-Martínez R, Miranda Fontes M, Márquez J, Armesto S, Belinchón I, Castañeda S, Casado A, Amaro A, Yébenes M, Sabater E, COEPSO Study Group

Patient’s preferences for psoriasis treatment based on a discrete choice experiment. COEPSO study

21th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018

García F, Domínguez-Hernández R, Alados JC, Casado M4, Macías J, Téllez F, Pascasio JM, Casado MA

Healthcare outcomes of one-step diagnosis in patients with chronic hepatitis C

21th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018

Marco A, Domínguez-Hernández R, Casado MA

Clinical and economic impact of the treatment of chronic hepatitis C in prison inmates in Spain

21th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018

Peral C, Navarro F, Montoro M, Balsa A, Gomez S, Pablos J, Martinez-Sesmero JM, Valderrama M, Oyagüez I, de Andrés-Nogales F, Casado MÁ

Cost-effectiveness of tofacitinib-containing sequences for rheumatoid arthritis patients in Spain

21th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018

Rico S, Echave M, Casado MA, Soto J

Systematic review of economic evaluations based on decisión-analytic modeling of cancer drugs

21th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018

Buti M, Ledesma F, Domínguez-Hernández R, Casado MÁ, Esteban R

Is the universal population hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence

21th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Barcelona. 10-14 nov 2018

Andrés Marco, Raquel Domínguez-Hernández, Miguel Ángel Casado

Cost-Effectiveness Analysis of the Treatment for Chronic Hepatitis C in Spanish Prisoners

The Liver Meeting® 2018. San Francisco (EEUU). 9-13 nov 2018

García F, Domínguez-Hernández R, Alados JC, Casado M, Macías J, Téllez F, Pascasio JM, Casado MA

La simplificación del proceso de diagnóstico de la hepatitis C crónica es una estrategia coste-efectiva

IV Congreso nacional del grupo de estudio de hepatitis víricas (GEHEP) de la SEIMC. Córdoba. 27-29 sep 2018